| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mind Medicine (MindMed) Inc. | Director | Common Shares | 17.4K | $104K | $5.98 | Aug 23, 2024 | Direct |
| Forte Biosciences, Inc. | Director | Stock Option (right to buy) | 50K | Aug 20, 2024 | Direct | ||
| Mind Medicine (MindMed) Inc. | Director | Stock Option (Right to Buy) | 16.5K | Jun 10, 2024 | Direct | ||
| AERIE PHARMACEUTICALS INC | Director | Common Stock | 0 | $15.25 | Nov 21, 2022 | By the Gryska Family Trust | |
| AERIE PHARMACEUTICALS INC | Director | Common Stock | 0 | $15.25 | Nov 21, 2022 | Direct | |
| AERIE PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | $9.14 | Nov 21, 2022 | Direct | |
| GW PHARMACEUTICALS PLC | Director | Share Options | 0 | May 5, 2021 | Direct | ||
| Seagen Inc. | Director | Common Stock | 0 | $229.00 | Dec 14, 2023 | Direct | |
| Seagen Inc. | Director | Restricted Stock Units | 0 | $229.00 | Dec 14, 2023 | Direct | |
| Seagen Inc. | Director | Stock Options (Right to Buy) | 0 | Dec 14, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MNMD | Mind Medicine (MindMed) Inc. | Aug 23, 2024 | 1 | $20.9K | 4 | Aug 26, 2024 | Director |
| FBRX | Forte Biosciences, Inc. | Aug 20, 2024 | 1 | $0 | 4 | Aug 22, 2024 | Director |
| MNMD | Mind Medicine (MindMed) Inc. | Jun 10, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
| SGEN | Seagen Inc. | Dec 14, 2023 | 11 | -$11.2M | 4 | Dec 15, 2023 | Director |
| FBRX | Forte Biosciences, Inc. | Sep 19, 2023 | 1 | $0 | 4 | Sep 20, 2023 | Director |
| FBRX | Forte Biosciences, Inc. | Jul 31, 2023 | 1 | $150K | 4 | Aug 2, 2023 | Director |
| MNMD | Mind Medicine (MindMed) Inc. | Jun 21, 2023 | 3 | $0 | 4 | Jun 23, 2023 | Director |
| MNMD | Mind Medicine (MindMed) Inc. | Jun 21, 2023 | 0 | $0 | 3 | Jun 23, 2023 | Director |
| SGEN | Seagen Inc. | May 31, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
| SGEN | Seagen Inc. | Feb 13, 2023 | 2 | $321K | 4 | Feb 15, 2023 | Director |
| FBRX | Forte Biosciences, Inc. | Jan 10, 2023 | 1 | $0 | 4 | Jan 12, 2023 | Director |
| FBRX | Forte Biosciences, Inc. | Jan 10, 2023 | 0 | $0 | 3 | Jan 12, 2023 | Director |
| AERI | AERIE PHARMACEUTICALS INC | Nov 21, 2022 | 4 | -$375K | 4 | Nov 21, 2022 | Director |
| SGEN | Seagen Inc. | Nov 11, 2022 | 1 | -$968K | 4 | Nov 15, 2022 | Director |
| AERI | AERIE PHARMACEUTICALS INC | Jun 9, 2022 | 2 | $0 | 4 | Jun 13, 2022 | Director |
| SGEN | Seagen Inc. | May 13, 2022 | 2 | $0 | 4 | May 17, 2022 | Director |
| SGEN | Seagen Inc. | Apr 19, 2022 | 9 | -$496K | 4 | Apr 21, 2022 | Director |
| SGEN | Seagen Inc. | Feb 7, 2022 | 9 | -$534K | 4 | Feb 9, 2022 | Director |
| SGEN | Seagen Inc. | Jan 28, 2022 | 12 | -$461K | 4 | Feb 1, 2022 | Director |
| SGEN | Seagen Inc. | Jan 14, 2022 | 3 | -$518K | 4 | Jan 19, 2022 | Director |
| AERI | AERIE PHARMACEUTICALS INC | Jun 17, 2021 | 2 | $0 | 4 | Jun 21, 2021 | Director |
| SGEN | Seagen Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |
| GWPH | GW PHARMACEUTICALS PLC | May 5, 2021 | 2 | $0 | 4 | May 7, 2021 | Director |